Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
Abstract
Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide Fabrizio Stocchi, Margherita Torti Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy Abstract: Safinamide (SAF) is a new drug developed for the treatment of Parkinson’s disease (PD). It is a benzylamino derivative with multiple mechanisms of action and antiparkinsonian, anticonvulsant, and neuroprotective properties. SAF...
Paper Details
Title
Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
Published Date
Feb 1, 2016
Pages
609 - 609
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History